Search

Reading Time: 2 minutes How CROs Adapt to Sponsors’ Desired Levels of Virtual Clinical Trials Sponsors depend on CROs to adapt—biopharmas outsource roughly 50% to CROs, and that percentage continues to grow each year. CROs who quickly adapt to virtualization using proven innovative technology complemented by an unmatched partnership experience gain a competitive edge, and the opportunity to rise above […]

Article

Reading Time: 2 minutes COVID-19 completely flipped the world of clinical trials on its head. While the pandemic has put many facets of daily life on pause, clinical trials have not stood still. CROs are called upon to deliver quick solutions in these unprecedented times to navigate site closures, changing regulations, and enabling virtual clinical trial solutions. Interrupted studies […]

Article

Reading Time: 2 minutes This post was guest authored by Dave McKie, vice president, marketing | Medidata Solutions, a Dassault Systèmes company By any measure, 2020 was a year to remember. For those of us in life sciences, 2020 was an opportunity to discover treatments for the COVID-19 pandemic. And the industry rose to the challenge, with one […]

Article

Reading Time: 3 minutesWhen clinical endpoints are subjective, image-based, or complex to assess, or the study is geographically broad, researchers of new drugs and devices may find it difficult to demonstrate acceptable safety results to regulatory authorities. To meet this requirement, trial sponsors and contract research organizations (CROs) are turning to clinical endpoint committees (CEC) for independent event […]

Article

Reading Time: 2 minutesToday’s agile clinical trial operations are grounded on the principles of Risk-based Quality Management (RBQM) using a data-centric strategy with actionable insights to enhance decision making capabilities. A successful RBQM strategy requires integration and harmonization across multiple data sources and complex workflows. Medidata is unifying RBQM and clinical trial management, delivering the ability to define […]

Article

Reading Time: 3 minutesThis blog was authored by Fiona Maini, global compliance and strategy principal, Medidata. The Value of eConsent Traditionally, the way to get a patient’s informed consent to participate in a clinical trial has been a paper-based process. A patient will sit with an investigator and go through pages and pages of information about the […]

Article

Reading Time: 2 minutes Meet Irfan, who works in front-end and middle-tier development as part of a team that works on the platform’s cloud admin. Hometown : Hyderabad, India Currently live: Secaucus, NJ Years at Medidata? 1 year this May Why did you join Medidata? After working in finance/fintech, gaming and HRM, I sought an opportunity to contribute towards […]

Article

Reading Time: 5 minutesThe Clinical Financial Blog was created to address the complexities that are encountered with financial management of clinical trials. With a lot of critical financial requirements still not being fully understood and addressed, we’ve got you covered. Medidata’s team of experts that have lived and breathed the budgeting and site payments processes for many years […]

Article

Reading Time: 2 minutesElectronic clinical outcome assessments (eCOA) have been used in clinical trials in some form or another for more than two decades. They are now the mainstream method of collecting pivotal outcome data in clinical trials, and we have definitely broached the “slope of enlightenment” into the “plateau of productivity” of the eCOA hype cycle, with […]

Article

Reading Time: 2 minutes Erika Singer, a member of the early talent acquisition team at Medidata, recently presented virtually to Rutgers University, University of California Berkeley, and Fordham University. Dozens of students from each university attended the info sessions and were eager to learn about Mediata and the potential opportunities we offer them both now and in the future. […]

Article

Reading Time: 4 minutesRuthie Davi, our VP of data science, and Jacob Aptekar, our senior director and trial design solutions lead, share their perspectives on the use of a Synthetic Control Arm, pioneered by Medidata Acorn AI, for more efficient trials in a regulatory setting. What is a Synthetic Control Arm? The randomized, controlled trial is well […]

Article

Reading Time: 2 minutesWe take pride in the Medidata way: Integrity. Honesty. Decency. Our fundamental values determine how we work and how we serve our customers. Trust is built and earned through years of commitment, accomplishment, and ethical behavior. At Medidata we’re proud of what we offer to the market because our technology and expertise consistently demonstrate these […]

Article